Literature DB >> 15381825

Endothelial protection from reperfusion injury by ischemic preconditioning and diazoxide involves a SOD-like anti-O2- mechanism.

M Maczewski1, M Duda, W Pawlak, A Beresewicz.   

Abstract

Cardiac ischemia/reperfusion leads to coronary endothelial dysfunction, mediated by superoxide anion (O2-), but not hydroxyl radical (*OH). Ischemic preconditioning and mitochondrial ATP-dependent potassium channel opener (diazoxide) protect endothelium in the mechanism involving attenuation of O2- burst at reperfusion. We hypothesize that the endothelial protection involves upregulation of myocardial anty-O2- defense. Langendorff-perfused guinea-pig hearts were subjected to global ischemia/reperfusion (IR) or were preconditioned prior to IR with three cycles of ischemia/reperfusion (IPC) or infusion/washout of 0.5 microM diazoxide. Coronary flow responses to acetylcholine were measures of endothelium-dependent vascular function. Myocardial outflow of O2- and of *OH during reperfusion and myocardial activities of superoxide dismutase (SOD) and catalase were measured. IR impaired acetylcholine response and augmented cardiac O2- and *OH outflow. IPC, diazoxide, and SOD (150 IU/ml) attenuated O2- outflow, increased *OH outflow and protected endothelium. There were no differences in Cu/Zn-SOD, Mn-SOD and catalase activities between sham-perfused and IR hearts and only catalase activity was increased in the IPC hearts. We speculate that: (i) IPC and diazoxide endothelial protection involves activation of some SOD-like anti-O2- mechanism resulting in attenuation of O2- burst and increase in *OH burst, (ii) improved SOD activity might have not been detected because it was confined to a small, although functionally important, enzyme fraction, like that bound to the endothelial glycocalyx.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381825

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  8 in total

Review 1.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 2.  The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.

Authors:  Derek J Hausenloy; William Chilian; Filippo Crea; Sean M Davidson; Peter Ferdinandy; David Garcia-Dorado; Niels van Royen; Rainer Schulz; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

3.  NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model.

Authors:  Sunil Potdar; Mahendra Kavdia
Journal:  Microvasc Res       Date:  2009-04-10       Impact factor: 3.514

4.  Chronic intermittent hypobaric hypoxia protects the heart against ischemia/reperfusion injury through upregulation of antioxidant enzymes in adult guinea pigs.

Authors:  Hui-Cai Guo; Zhe Zhang; Li-Nan Zhang; Chen Xiong; Chen Feng; Qian Liu; Xu Liu; Xiao-Lu Shi; Yong-Li Wang
Journal:  Acta Pharmacol Sin       Date:  2009-06-22       Impact factor: 6.150

5.  Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart.

Authors:  By Alison L Müller; Naranjan S Dhalla
Journal:  Curr Cardiol Rev       Date:  2010-11

6.  Liver ischemia preconditions the heart against ischemia-reperfusion arrhythmias.

Authors:  Mohammad-Foad Noorbakhsh; Hossein-Ali Arab; Hamid-Reza Kazerani
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

7.  Preventive Effect of Blueberry Extract on Liver Injury Induced by Carbon Tetrachloride in Mice.

Authors:  Bihui Liu; Yuan Fang; Ruokun Yi; Xin Zhao
Journal:  Foods       Date:  2019-02-01

Review 8.  Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control.

Authors:  Xing Chang; Amanda Lochner; Hsueh-Hsiao Wang; Shuyi Wang; Hang Zhu; Jun Ren; Hao Zhou
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.